Clinical Trial Update: A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures. [Phase 3]

View source ↗

Summary

A phase 3 placebo-controlled trial evaluating levetiracetam in young children (1 month to 4 years) with partial onset seizures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy Partial

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Epilepsy, Partial | Phase 3 | Status: COMPLETED